This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Weiner, S M Articles by Peter, H H Search for Related Content PubMed PubMed Citation Articles by Weiner, S M Articles by Peter, H H Social Bookmarking                         What's this?

Alterations of cerebral glucose metabolism indicate progress to severe morphological brain lesions in neuropsychiatric systemic lupus erythematosus

Department of Rheumatology and Clinical Immunology, University Hospital, Hugstetterstrasse 55, D-79106 Freiburg, Germany. Tel: (/ 49) 761 2703347; Fax: (/ 49) 761 2703446; weiner{at}mm61.ukl.uni-freiburg.de

A Otte

Institute of Nuclear Medicine, University Hospital, Basel, Switzerland

M Schumacher

Department of Neuroradiology

I Brink

F D Juengling

Department of Nuclear Medicine

T Sobanksi

Department of Psychiatry, University Hospital, Freiburg, Germany

E U Nitzsche

Department of Nuclear Medicine

H H Peter

Department of Rheumatology and Clinical Immunology

Neuropsychiatric systemic lupus erythematosus (SLE) is frequently associated with deficits in brain glucose metabolism, even if morphological imaging by magnetic resonance imaging (MRI) shows no abnormalities. In these patients it is unclear whether or not the changes of brain metabolism measured by F-18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) may progress to lesions of cerebral structure. We describe a 20-year-old woman with SLE who presented with depression, headache and impairment of memory. Initially, a cranial MRI was negative, but FDG-PET revealed significant hypometabolism in the frontal and parieto-temporo-occipital regions on both sides as well as hypermetabolism in the nuclei caudati. Within two months the patient developed an acute confusional state, seizures, visual disturbances and cranial MRI became positive showing hyperintensities at the basal ganglia and the temporo-occipital regions. Focal cerebral symptoms responded to treatment with high dose corticosteroids and brain lesions in MRI disappeared. However, a second FDG-PET showed persistent hypometabolism at frontal regions in accordance with the persistence of subclinical depression. To our knowledge, this is the first SLE case report showing that functional brain lesions visualized by FDG-PET may be a risk factor for subsequent structural brain damage seen in MRI. Thus, FDG-PET may help to verify cerebral involvement of SLE earlier than MRI.

Key Words: F-18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) • magnetic resonance imaging (MRI) • neuropsychiatric • systemic lupus erythematosus (SLE)

Lupus, Vol. 9, No. 5, 386-389 (2000)
DOI: 10.1191/096120300678828370


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?